Zoetis Inc. ZTS

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $73.74
Market Cap $31.78B
P/E Ratio 12.25
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑2.3% YoY
$9.47B
3-Yr CAGR: 5.4%
Net Income ↑7.5% YoY
$2.67B
Net Margin: 28.2%
Free Cash Flow ↓-0.7% YoY
$2.28B
FCF Yield: 7.18%
EPS (Diluted) ↑10.1% YoY
$6.02
Basic: $6.03
Return on Equity Efficiency
80.2%
ROA: 39.5%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ZTS)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $4,888.0M $3,222.0M $821.0M $1.65 $713.0M $497.0M
FY 2017 $5,307.0M +8.6% $3,532.0M $864.0M +5.2% $1.75 +6.1% $1,346.0M $1,122.0M +125.8%
FY 2018 $5,825.0M +9.8% $3,914.0M $1,428.0M +65.3% $2.93 +67.4% $1,790.0M $1,452.0M +29.4%
FY 2019 $6,260.0M +7.5% $4,268.0M $1,500.0M +5.0% $3.11 +6.1% $1,795.0M $1,335.0M -8.1%
FY 2020 $6,675.0M +6.6% $4,618.0M $1,638.0M +9.2% $3.42 +10.0% $2,126.0M $1,673.0M +25.3%
FY 2021 $7,776.0M +16.5% $5,473.0M $2,037.0M +24.4% $4.27 +24.9% $2,213.0M $1,736.0M +3.8%
FY 2022 $8,080.0M +3.9% $5,626.0M $2,114.0M +3.8% $4.49 +5.2% $1,912.0M $1,326.0M -23.6%
FY 2023 $8,544.0M +5.7% $5,983.0M $2,344.0M +10.9% $5.07 +12.9% $2,353.0M $1,621.0M +22.2%
FY 2024 $9,256.0M +8.3% $6,537.0M $2,486.0M +6.1% $5.47 +7.9% $2,953.0M $2,298.0M +41.8%
FY 2025 $9,467.0M +2.3% $6,801.0M $2,673.0M +7.5% $6.02 +10.1% $2,904.0M $2,283.0M -0.7%
$

Valuation

Market Price $73.74
Market Cap $31.78B
Enterprise Value $39.26B
P/E Ratio 12.25
P/B Ratio 9.28
FCF Yield 7.18%
Dividend Yield N/A
Shares Outstanding 419,228,100
%

Profitability & Margins

Gross Margin 71.84%
Operating Margin 0.06%
Net Margin 28.23%
Return on Equity (ROE) 80.25%
Return on Assets (ROA) 39.49%
Asset Turnover 1.40x
Revenue 3-Yr CAGR 5.42%
🛡️

Financial Health & Liquidity

Current Ratio 7.94
Cash Ratio 1.84
Debt / Equity 2.715
Debt / Assets 1.336
Cash & Equivalents $1.56B
Total Debt $9.04B
Book Value / Share $7.95
💧

Cash Flow Efficiency

Operating Cash Flow $2.90B
Capital Expenditures (CapEx) $621.00M
Free Cash Flow $2.28B
OCF / Revenue 30.67%
FCF / Revenue 24.12%
FCF 3-Yr CAGR 19.85%
🏷️

Per Share Metrics

EPS (Diluted) $6.02
EPS (Basic) $6.03
Dividends / Share N/A
Book Value / Share $7.95
EPS YoY Growth 10.05%
🏛️

Balance Sheet (FY 2025)

Total Assets $6.77B
Total Liabilities $852.00M
Stockholders' Equity $3.33B
Current Assets $6.77B
Current Liabilities $852.00M